Idera
is a Pennsylvania-based biopharmaceutical company that researches and develops novel drugs for the treatment of autoimmune and inflammatory diseases... Read moreIdera
is a Pennsylvania-based biopharmaceutical company that researches and develops novel drugs for the treatment of autoimmune and inflammatory diseases... Read more
CEO
John Taylor
News
Jan 17, 2023
GlobalNewswire
Press Release: Idera : Idera Pharmaceuticals Announces Name Change to Aceragen, Inc. and Provides Near-Term Strategic Outlook
Nov 15, 2022
Marketscreener
Idera: Idera: Q3 Earnings Snapshot
Nov 14, 2022
Seeking Alpha
Idera: Idera Pharmaceuticals GAAP EPS of -$0.06, revenue of $0.05M
Sep 29, 2022
The Business Journals: Raleigh/Durham
Idera: Durham CEO now leads public company following acquisition
Jul 06, 2022
MarketScreener
Idera: Idera Pharmaceuticals : Statement of Changes in Beneficial Ownership (Form 4)
May 17, 2022
StreetInsider
Press Release: Idera : Idera Pharmaceuticals Shares Positive Results from Investigator-Sponsored Trial in Melanoma Patients at Amsterdam UMC
May 05, 2022
FirstWord Pharma
Idera: Idera Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
Mar 31, 2022
GlobeNewswire
Press Release: Idera : Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Mar 31, 2022
Associated Press News
Idera: Idera: Q4 Earnings Snapshot
Dec 15, 2021
Endpoints News
Idera: Idera Pharmaceuticals' stock tanks after AbbVie cuts enrollment early in a PhIb trial
Idera Competitors
1
2
3
4
5
6
7
8
9
10